CAMBRIDGE, MA--(Marketwire - March 04, 2009) -
PharmaPros, a technical solutions provider
specializing in data and workflow management for clinical trials, today
announced that Capstone Therapeutics has selected the company's data
lifecycle management solution, Dataflow Manager, for its Phase 2 study to
evaluate the safety and preliminary efficacy of AZX100 in trocar sites of
arthroscopic shoulder surgery patients. Capstone Therapeutics (trade name
of OrthoLogic Corp.) is a biotechnology company committed to developing a
pipeline of novel therapeutic peptides aimed at helping patients with
under-served medical conditions.
"PharmaPros and Capstone share philosophical synergies from our multiple
trial engagements," said Peg Regan, CEO of PharmaPros. "Dataflow Manager,
which will be utilized as Capstone's trial management interface,
underscores this joint philosophy: achieving higher quality data through
in-stream data access and maintaining control of the data throughout its
lifecycle."
During the trial, Capstone and its service providers will utilize Dataflow
Manager as its central interface to track and manage clinical information
for the Phase 2 study. Using virtual integration, Dataflow Manager will
provide an integrated view of study metrics in-stream, including patient
data via EDC, safety data, 2D & 3D medical images and image findings data,
and laboratory data. Dataflow Manager will also provide Capstone
statisticians with on-demand outputs of integrated datasets for in-stream
data analysis.
The Dataflow Manager solution for Capstone includes a PharmaPros Data
Lifecycle Manager who will collaborate with Capstone throughout the study
using Dataflow Manager's interactive reporting dashboards to track data
readiness for interim-analysis, ensure timely entry of data at the
investigator sites, manage technology vendors and assist project teams in
ensuring critical milestones and timelines are being met.
"We are pleased to be working with PharmaPros and to be using Dataflow
Manager," said Joan Matusin, RN, Senior Director, Clinical Operations,
Capstone Therapeutics. "The program interface allows our company to retain
the level of control and visibility necessary to ensure successful
execution of our studies."
Dataflow Manager is a first-in-class solution that facilitates in-stream
Data Lifecycle Management, the next generation of managing clinical trials
data. Using virtual integration and process automation, Dataflow Manager
empowers companies to proactively manage clinical trials across multiple
data systems and vendors, and against expected milestones and timelines.
About Capstone Therapeutics
Capstone Therapeutics (trade name of OrthoLogic Corp.) is a biotechnology
company committed to developing a pipeline of novel therapeutic peptides
aimed at helping patients with under-served medical conditions. The Company
is focused on development and commercialization of two product platforms:
AZX100 and Chrysalin® (rusalatide acetate or TP508).
Capstone's corporate headquarters are in Tempe, Arizona. For more
information, please visit the Company's website: www.capstonethx.com.
About PharmaPros Corporation
PharmaPros Corporation is a technical solutions provider specializing in
data and workflow management for clinical trials. Through its
first-in-class product, Dataflow Manager™, the company is pioneering the
next generation in workflow technology to support the entire data lifecycle
for clinical trials. PharmaPros was founded in 1996 and is headquartered in
Cambridge, Massachusetts.
